Is Astrana Health, Inc. (ASTH) a Buy, Sell, or Hold?
NASDAQ : ASTH
Astrana Health, Inc. — Insider Trades
$40.99 USD
-$0.95 (-2.27%)
- Volume
- 869.86K
- Average Volume
- 588.29K
- Market Capitalization
- $2.03B
- P/E Ratio
- 66.37
- Dividend Yield
- 0.00%
- Price Target
- $47.00
- Year High
- $51.60
- Year Low
- $18.08
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.08
- Current Ratio
- $1.35
Insider Activity Summary (Last 12 Months)
Insiders Buying
20
Insiders Selling
31
Amount of Insider Selling
$400.02K
ASTH Insider Buying/Selling by Quarter
ASTH Insider Trading History
| Insider Name | Title | Date | Transaction | Cost | Filing Date |
|---|---|---|---|---|---|
| Sim Brandon | officer: CEO and President | 2026-06-27 | F-InKind | 44.51 | 2026-06-30 |
| Schmidt David | director | 2026-06-10 | A-Award | 0 | 2026-06-12 |
| Mazdyasni Matthew | director | 2026-06-10 | A-Award | 0 | 2026-06-12 |
| Kitayama Mitchell W | director | 2026-06-10 | A-Award | 0 | 2026-06-12 |
| Dong Linda | director | 2026-06-10 | A-Award | 0 | 2026-06-12 |
| Dai, Weili | director | 2026-06-10 | A-Award | 0 | 2026-06-12 |
| Chiang John | director | 2026-06-10 | A-Award | 0 | 2026-06-12 |
| Basho Chandan | officer: COO and CFO | 2026-05-16 | F-InKind | 38.26 | 2026-05-18 |
| Basho Chandan | officer: COO and CFO | 2026-04-14 | F-InKind | 29.07 | 2026-04-15 |
| Lam Thomas S. | director | 2026-04-06 | A-Award | 0 | 2026-04-08 |
| Sim Kenneth T. | director, officer: Executive Chairman | 2026-04-06 | A-Award | 0 | 2026-04-08 |
| Sim Brandon | officer: CEO and President | 2026-04-06 | A-Award | 0 | 2026-04-08 |
| Kumar Dinesh M. | officer: Chief Medical Officer | 2026-04-01 | A-Award | 0 | 2026-04-03 |
| Kumar Dinesh M. | officer: Chief Medical Officer | 2026-04-01 | F-InKind | 24.51 | 2026-04-03 |
| Basho Chandan | officer: COO and CFO | 2026-04-02 | F-InKind | 25.05 | 2026-04-03 |
| Sobotka Glenn | officer: Chief Accounting Officer | 2026-03-26 | F-InKind | 24.27 | 2026-03-30 |
| Lam Thomas S. | director | 2026-03-05 | F-InKind | 25.07 | 2026-03-09 |
| Kumar Dinesh M. | officer: Chief Medical Officer | 2026-03-05 | F-InKind | 25.07 | 2026-03-09 |
| Basho Chandan | officer: COO and CFO | 2026-03-05 | F-InKind | 25.07 | 2026-03-09 |
| Sim Brandon | officer: CEO and President | 2026-02-02 | M-Exempt | 23.24 | 2026-02-03 |
| Sim Brandon | officer: CEO and President | 2026-02-02 | M-Exempt | 23.24 | 2026-02-03 |
| Kumar Dinesh M. | officer: Chief Medical Officer | 2026-01-23 | F-InKind | 27.16 | 2026-01-27 |
| Schmidt David | director | 2026-01-13 | M-Exempt | 5.79 | 2026-01-15 |
| Schmidt David | director | 2026-01-13 | F-InKind | 27.12 | 2026-01-15 |
| Schmidt David | director | 2026-01-13 | M-Exempt | 5.79 | 2026-01-15 |
| Kumar Dinesh M. | officer: Chief Medical Officer | 2026-01-01 | F-InKind | 24.81 | 2026-01-05 |
| Lam Thomas S. | director | 2025-12-08 | M-Exempt | 17.78 | 2025-12-10 |
| Lam Thomas S. | director | 2025-12-08 | F-InKind | 22 | 2025-12-10 |
| Lam Thomas S. | director | 2025-12-08 | M-Exempt | 17.78 | 2025-12-10 |
| Sim Kenneth T. | director, officer: Executive Chairman | 2025-11-10 | M-Exempt | 17.78 | 2025-11-13 |
| Sim Kenneth T. | director, officer: Executive Chairman | 2025-11-10 | M-Exempt | 17.78 | 2025-11-13 |
| Kitayama Mitchell W | director | 2025-11-07 | M-Exempt | 18.2 | 2025-11-12 |
| Kitayama Mitchell W | director | 2025-11-07 | M-Exempt | 18.2 | 2025-11-12 |
| Mazdyasni Matthew | director | 2025-11-10 | M-Exempt | 18.2 | 2025-11-12 |
| Mazdyasni Matthew | director | 2025-11-10 | M-Exempt | 18.2 | 2025-11-12 |
| Marsh Linda | director | 2025-11-03 | M-Exempt | 18.2 | 2025-11-05 |
| Marsh Linda | director | 2025-11-03 | F-InKind | 32.99 | 2025-11-05 |
| Marsh Linda | director | 2025-11-03 | M-Exempt | 18.2 | 2025-11-05 |
| Basho Chandan | officer: COO and CFO | 2025-10-02 | F-InKind | 27.77 | 2025-10-06 |
| Kitayama Mitchell W | director | 2025-09-15 | M-Exempt | 18.2 | 2025-09-15 |
| Kitayama Mitchell W | director | 2025-09-15 | D-Return | 30.23 | 2025-09-15 |
| Kitayama Mitchell W | director | 2025-09-15 | D-Return | 30.23 | 2025-09-15 |
| Kitayama Mitchell W | director | 2025-09-15 | M-Exempt | 18.2 | 2025-09-15 |
| Basho Chandan | officer: COO and CFO | 2025-09-05 | F-InKind | 29.7 | 2025-09-09 |
| Kumar Dinesh M. | officer: Chief Medical Officer | 2025-09-05 | F-InKind | 29.7 | 2025-09-09 |
| Schmidt David | director | 2025-09-02 | M-Exempt | 18.2 | 2025-09-03 |
| Schmidt David | director | 2025-09-02 | D-Return | 27.76 | 2025-09-03 |
| Schmidt David | director | 2025-09-02 | M-Exempt | 18.2 | 2025-09-03 |
| Chiang John | director | 2025-08-13 | M-Exempt | 18.2 | 2025-08-14 |
| Chiang John | director | 2025-08-13 | F-InKind | 29.63 | 2025-08-14 |
| Chiang John | director | 2025-08-13 | M-Exempt | 18.2 | 2025-08-14 |
| Kumar Dinesh M. | officer: Chief Medical Officer | 2025-07-01 | F-InKind | 25.06 | 2025-07-02 |
| Mazdyasni Matthew | director | 2025-06-11 | A-Award | 0 | 2025-06-13 |
| Marsh Linda | director | 2025-06-11 | A-Award | 0 | 2025-06-13 |
| Kitayama Mitchell W | director | 2025-06-11 | A-Award | 0 | 2025-06-13 |
| Dai, Weili | director | 2025-06-11 | A-Award | 0 | 2025-06-13 |
| Chiang John | director | 2025-06-11 | A-Award | 0 | 2025-06-13 |
| Schmidt David | director | 2025-06-11 | A-Award | 0 | 2025-06-13 |
| Kumar Dinesh M. | officer: Chief Medical Officer | 2025-06-04 | F-InKind | 25.06 | 2025-06-06 |
| Basho Chandan | officer: COO and CFO | 2025-05-16 | F-InKind | 27.18 | 2025-05-19 |
| Kumar Dinesh M. | officer: Chief Medical Officer | 2025-04-29 | F-InKind | 31.15 | 2025-04-30 |
| Basho Chandan | officer: COO and CFO | 2025-04-14 | F-InKind | 34.05 | 2025-04-16 |
| Basho Chandan | officer: COO and CFO | 2025-04-02 | F-InKind | 30.02 | 2025-04-03 |
| Sobotka Glenn | officer | 2025-03-26 | 0 | 2025-03-28 | |
| Sobotka Glenn | officer: Chief Accounting Officer | 2025-03-26 | A-Award | 0 | 2025-03-28 |
| Sobotka Glenn | officer: Chief Accounting Officer | 2025-03-26 | A-Award | 0 | 2025-03-28 |
| Sim Brandon | officer: CEO and President | 2025-03-05 | A-Award | 0 | 2025-03-07 |
| Sim Brandon | officer: CEO and President | 2025-03-05 | F-InKind | 27.19 | 2025-03-07 |
| Basho Chandan | officer: COO and CFO | 2025-03-05 | A-Award | 0 | 2025-03-07 |
| Lam Thomas S. | director | 2025-03-05 | F-InKind | 27.19 | 2025-03-07 |
| Kumar Dinesh M. | officer: Chief Medical Officer | 2025-03-05 | A-Award | 0 | 2025-03-07 |
| Kumar Dinesh M. | officer: Chief Medical Officer | 2025-03-05 | F-InKind | 27.19 | 2025-03-07 |
| Sim Kenneth T. | director, officer: Executive Chairman | 2025-02-15 | J-Other | 0 | 2025-02-18 |
| Sim Kenneth T. | director, officer: Executive Chairman | 2025-02-15 | J-Other | 0 | 2025-02-18 |
| ALLIED PHYSICIANS OF CALIFORNIA, A PROFESSIONAL MEDICAL Corp | 10 percent owner | 2025-02-15 | J-Other | 0 | 2025-02-18 |
| Lam Thomas S. | director | 2025-02-15 | J-Other | 0 | 2025-02-18 |
| Lam Thomas S. | director | 2025-02-15 | J-Other | 0 | 2025-02-18 |
| Kumar Dinesh M. | officer: Chief Medical Officer | 2025-01-23 | F-InKind | 37.96 | 2025-01-27 |
| ALLIED PHYSICIANS OF CALIFORNIA, A PROFESSIONAL MEDICAL Corp | 10 percent owner | 2025-01-17 | D-Return | 35.17 | 2025-01-22 |
| Kumar Dinesh M. | officer: Chief Medical Officer | 2025-01-01 | F-InKind | 31.53 | 2025-01-03 |
| Kitayama Mitchell W | director | 2024-12-10 | D-Return | 43.09 | 2024-12-12 |
| Vong John | officer: Chief Accounting Officer | 2024-11-30 | F-InKind | 43.25 | 2024-12-03 |
| Kitayama Mitchell W | director | 2024-11-22 | M-Exempt | 18.41 | 2024-11-26 |
| Kitayama Mitchell W | director | 2024-11-22 | F-InKind | 42.11 | 2024-11-26 |
| Kitayama Mitchell W | director | 2024-11-22 | M-Exempt | 18.41 | 2024-11-26 |
| Chiang John | director | 2024-11-19 | M-Exempt | 18.41 | 2024-11-20 |
| Chiang John | director | 2024-11-19 | F-InKind | 40.93 | 2024-11-20 |
| Chiang John | director | 2024-11-19 | M-Exempt | 18.41 | 2024-11-20 |
| Sim Kenneth T. | director, officer: Executive Chairman | 2024-11-18 | M-Exempt | 18.65 | 2024-11-20 |
| Sim Kenneth T. | director, officer: Executive Chairman | 2024-11-18 | M-Exempt | 18.65 | 2024-11-20 |
| Vong John | officer: Chief Accounting Officer | 2024-11-12 | F-InKind | 42.91 | 2024-11-13 |
| Kumar Dinesh M. | officer: See remarks | 2024-11-08 | A-Award | 0 | 2024-11-12 |
| Basho Chandan | officer: COO and CFO | 2024-11-08 | A-Award | 0 | 2024-11-12 |
| Basho Chandan | officer: COO and CFO | 2024-11-08 | F-InKind | 46.96 | 2024-11-12 |
| Sim Brandon | officer: CEO and President | 2024-11-08 | A-Award | 0 | 2024-11-12 |
| Lam Thomas S. | director | 2024-11-08 | A-Award | 0 | 2024-11-12 |
| Lam Thomas S. | director | 2024-11-08 | A-Award | 0 | 2024-11-12 |
| Sim Kenneth T. | director, officer: Executive Chairman | 2024-11-08 | A-Award | 0 | 2024-11-12 |
| Sim Kenneth T. | director, officer: Executive Chairman | 2024-11-08 | A-Award | 0 | 2024-11-12 |
| Sim Brandon | officer: CEO and President | 2024-10-02 | F-InKind | 57.87 | 2024-10-04 |